A multi-scale pipeline linking drug transcriptomics with pharmacokinetics predicts in vivo interactions of tuberculosis drugs
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multi-scale pipeline linking drug transcriptomics with pharmacokinetics predicts in vivo interactions of tuberculosis drugs
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-11
DOI
10.1038/s41598-021-84827-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
- (2020) Francesca Conradie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Both Pharmacokinetic Variability and Granuloma Heterogeneity Impact the Ability of the First-Line Antibiotics to Sterilize Tuberculosis Granulomas
- (2020) Joseph M. Cicchese et al. Frontiers in Pharmacology
- The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019
- (2019) A. D. Pranger et al. DRUGS
- Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment
- (2019) Murat Cokol et al. PLoS Computational Biology
- Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization
- (2019) Natasha Strydom et al. PLOS MEDICINE
- Modelling the effects of bacterial cell state and spatial location on tuberculosis treatment: Insights from a hybrid multiscale cellular automaton model
- (2018) Ruth Bowness et al. JOURNAL OF THEORETICAL BIOLOGY
- Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas
- (2018) Elsje Pienaar et al. PLoS One
- Molecular mechanism of the synergistic activity of ethambutol and isoniazid against Mycobacterium tuberculosis
- (2018) Chen Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
- (2017) Dennis Falzon et al. EUROPEAN RESPIRATORY JOURNAL
- Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach
- (2017) Elsje Pienaar et al. PLoS Computational Biology
- Experimental study of tuberculosis: From animal models to complex cell systems and organoids
- (2017) Kaori L. Fonseca et al. PLoS Pathogens
- Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
- (2017) Murat Cokol et al. Science Advances
- Integration of Metabolomics and Transcriptomics Reveals a Complex Diet of Mycobacterium tuberculosis during Early Macrophage Infection
- (2017) Michael Zimmermann et al. mSystems
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
- (2017) Michiru Nishita et al. Scientific Reports
- Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests
- (2016) Soumya Swaminathan et al. CLINICAL INFECTIOUS DISEASES
- Multiscale Model of Mycobacterium tuberculosis Infection Maps Metabolite and Gene Perturbations to Granuloma Sterilization Predictions
- (2016) Elsje Pienaar et al. INFECTION AND IMMUNITY
- Tuberculosis
- (2016) Keertan Dheda et al. LANCET
- Chemogenomics and orthology‐based design of antibiotic combination therapies
- (2016) Sriram Chandrasekaran et al. Molecular Systems Biology
- Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model
- (2016) Aleidy Silva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prediction of Drug Penetration in Tuberculosis Lesions
- (2016) Jansy P. Sarathy et al. ACS Infectious Diseases
- In silico evaluation and exploration of antibiotic tuberculosis treatment regimens
- (2015) Elsje Pienaar et al. BMC Systems Biology
- A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment
- (2015) Elsje Pienaar et al. JOURNAL OF THEORETICAL BIOLOGY
- The association between sterilizing activity and drug distribution into tuberculosis lesions
- (2015) Brendan Prideaux et al. NATURE MEDICINE
- Antibiotic efficacy is linked to bacterial cellular respiration
- (2015) Michael A. Lobritz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets
- (2015) K. Mdluli et al. Cold Spring Harbor Perspectives in Medicine
- Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies
- (2015) Alimuddin Zumla et al. Lancet Respiratory Medicine
- Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
- (2014) Emmanuel Chigutsa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Computational Modeling Predicts IL-10 Control of Lesion Sterilization by Balancing Early Host Immunity–Mediated Antimicrobial Responses with Caseation duringMycobacterium tuberculosisInfection
- (2014) Nicholas A. Cilfone et al. JOURNAL OF IMMUNOLOGY
- The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
- (2014) Véronique Dartois NATURE REVIEWS MICROBIOLOGY
- Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
- (2014) Stephen H. Gillespie et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
- (2014) Amina Jindani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection
- (2013) Nicholas A. Cilfone et al. PLoS One
- Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy
- (2012) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Ethambutol in South African Tuberculosis Patients
- (2011) Siv Jönsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiscale Computational Modeling Reveals a Critical Role for TNF- Receptor 1 Dynamics in Tuberculosis Granuloma Formation
- (2011) M. Fallahi-Sichani et al. JOURNAL OF IMMUNOLOGY
- Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model
- (2009) P. L. Lin et al. INFECTION AND IMMUNITY
- Synergy between Individual TNF-Dependent Functions Determines Granuloma Performance for Controlling Mycobacterium tuberculosis Infection
- (2009) J. C. J. Ray et al. JOURNAL OF IMMUNOLOGY
- A methodology for performing global uncertainty and sensitivity analysis in systems biology
- (2008) Simeone Marino et al. JOURNAL OF THEORETICAL BIOLOGY
- Drug interactions modulate the potential for evolution of resistance
- (2008) J.-B. Michel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started